Prevalence of adverse reactions to intravenously administered originator biologics in patients with rheumatoid arthritis: A 5-year retrospective study

• Main Authors: Haya M. Almalag (Author), Shiekha S. Alaujan (Author), Hawazin S. Alhazzani (Author), Lamia A. Alzamel (Author), Reem S. Tashkandi (Author), Hussain F. Alarfaj (Author), Abdurhman S. Alarfaj (Author), Mohammed A. Omair (Author)
• Format: Book
• Published: Elsevier, 2022-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Few Saudi studies have examined adverse drug reactions (ADRs) in patients with rheumatoid arthritis (RA) receiving intravenous (IV) originator biologics. Therefore, this study aimed to evaluate the prevalence, types, and predictors of ADRs following long-term IV originator biologic use i...